Astrana Health Inc. (ASTH)
Astrana Health Statistics
Share Statistics
Astrana Health has 50.12M shares outstanding. The number of shares has increased by 2.51% in one year.
| Shares Outstanding | 50.12M |
| Shares Change (YoY) | 2.51% |
| Shares Change (QoQ) | 2.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 37.29M |
| Failed to Deliver (FTD) Shares | 85 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.6M, so 3.26% of the outstanding shares have been sold short.
| Short Interest | 1.6M |
| Short % of Shares Out | 3.26% |
| Short % of Float | 4.45% |
| Short Ratio (days to cover) | 4.39 |
Valuation Ratios
The PE ratio is 34.85 and the forward PE ratio is 18.74. Astrana Health's PEG ratio is -1.13.
| PE Ratio | 34.85 |
| Forward PE | 18.74 |
| PS Ratio | 0.74 |
| Forward PS | 0.4 |
| PB Ratio | 2.11 |
| P/FCF Ratio | 34.04 |
| PEG Ratio | -1.13 |
Enterprise Valuation
Astrana Health has an Enterprise Value (EV) of 1.38B.
| EV / Sales | 0.68 |
| EV / EBITDA | 9.73 |
| EV / EBIT | 26.44 |
| EV / FCF | 31.24 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.43 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.8 |
| Interest Coverage | 2.7 |
Financial Efficiency
Return on Equity is 6.05% and Return on Invested Capital is 7.56%.
| Return on Equity | 6.05% |
| Return on Assets | 3.18% |
| Return on Invested Capital | 7.56% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | $22.71K |
| Employee Count | 1,900 |
| Asset Turnover | 1.5 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 30.89M |
| Effective Tax Rate | 38.22% |
Stock Price Statistics
The stock price has increased by -28.36% in the last 52 weeks. The beta is 1.3, so Astrana Health's price volatility has been higher than the market average.
| Beta | 1.3 |
| 52-Week Price Change | -28.36% |
| 50-Day Moving Average | 33.45 |
| 200-Day Moving Average | 43.24 |
| Relative Strength Index (RSI) | 44.2 |
| Average Volume (20 Days) | 356.02K |
Income Statement
In the last 12 months, Astrana Health had revenue of 2.03B and earned 43.15M in profits. Earnings per share was 0.9.
| Revenue | 2.03B |
| Gross Profit | 271.39M |
| Operating Income | 89.35M |
| Net Income | 43.15M |
| EBITDA | 141.84M |
| EBIT | 113.92M |
| Earnings Per Share (EPS) | 0.9 |
Balance Sheet
The company has 158.92M in cash and 35.27M in debt, giving a net cash position of 123.65M.
| Cash & Cash Equivalents | 158.92M |
| Total Debt | 35.27M |
| Net Cash | 123.65M |
| Retained Earnings | 286.28M |
| Total Assets | 1.35B |
| Working Capital | 272.89M |
Cash Flow
In the last 12 months, operating cash flow was 52.2M and capital expenditures -8.03M, giving a free cash flow of 44.17M.
| Operating Cash Flow | 52.2M |
| Capital Expenditures | -8.03M |
| Free Cash Flow | 44.17M |
| FCF Per Share | 0.93 |
Margins
Gross margin is 13.34%, with operating and profit margins of 4.39% and 2.12%.
| Gross Margin | 13.34% |
| Operating Margin | 4.39% |
| Pretax Margin | 3.97% |
| Profit Margin | 2.12% |
| EBITDA Margin | 6.97% |
| EBIT Margin | 4.39% |
| FCF Margin | 2.17% |
Dividends & Yields
ASTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.87% |
| FCF Yield | 2.94% |
Analyst Forecast
The average price target for ASTH is $50, which is 65.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $50 |
| Price Target Difference | 65.8% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Apr 27, 2015. It was a backward split with a ratio of 1:10.
| Last Split Date | Apr 27, 2015 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 3.38 |
| Piotroski F-Score | 6 |